Thursday 18 July | |
Scieifitic Digital Imaging | Half Year Results |
Audioboom | Half Year Results |
SRT Marines | Half Year Results |
SSE | Q1 Results |
Centamin | Q2 Results |
SSP Group | Q3 Results |
Moneysupermarket.com | Half Year Results |
Hilton Food Group | Trading Statement |
Anglo American | Half Year Production |
AO World | Q1 Results |
Royal Mail | Trading Statement |
easyJet | Q3 Results |
Hotel Chocolat | Trading Statement |
Friday 19 July | |
Close Brothers | Trading Statement |
Record | Q1 Results |
Homeserve | Trading Statement |
British Land | Trading Statement |
Monday 22 July | |
Abcam | Trading Statement |
Midwich Group | Trading Statement |
Ascential | Half Year Results |
Sthree | Half Year Results |
Tungsten | Full Year Results |
JTC | Trading Statement |
Tuesday 23 July | |
Beazley | Half Year Results |
Carclo | Full Year Results |
Photo-Me International | Full Year Results |
ASOS | Q3 Results |
Daejan Holdings | Full Year Results |
Scapa Group | Trading Statement |
Fevertree Drinks | Half Year Results |
Dotdigital Group | Trading Statement |
McColl's Retail Group | Half Year Results |
Paragon Banking Group | Q3 Results |
IG Group | Full Year Results |
FDM Group | Half Year Results |
Gresham Technologies | Half Year Results |
PZ Cussons | Full Year Results |
Joules Group | Full Year Results |
Petropavlovsk | Full Year Results |
Unite Group | Half Year Results |
Huntsworth | Half Year Results |
Wednesday 24 July | |
Tullow Oil | Half Year Results |
Paypoint | Q1 Results |
SEGRO | Half Year Results |
Law Debenture | Half Year Results |
Quartix Holdings | Half Year Results |
Metro Bank | Half Year Results |
Marston's | Trading Statement |
ITV | Half Year Results |
GlaxoSmithKline | Half Year Results (at 1200 BST) |
Antofagasta | Half Year Production |
Rathbone Brothers | Half Year Results |
Informa | Half Year Results |
Croda International | Half Year Results |
Britvic | Q3 Results |
Drax Group | Half Year Results |
Headlam Group | Trading Statement |
GSK seeks to extend RSV vaccine approval in Japan
(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.
Read more